Clinical trial Recruiting at 1 site Early Phase 1 Interventional Women only

Adapalene gel vs. Biafine for acute radiation dermatitis in adults receiving radiotherapy

Official title: A Single-Center, Open-Label, Randomized Controlled Trial Evaluating the Efficacy and Safety of Adapalene Gel in Patients Receiving Radiotherapy Who Develop Acute Radiation Dermatitis

Run by Yunnan Cancer Hospital · NCT07886320 · Data updated 2026-11-12

A gel containing adapalene is being tested to see if it helps with skin injury from radiation compared with Biafine in adults undergoing radiotherapy.

More Radiation Dermatitis trials

Quick facts

PhaseEarly Phase 1
Study typeInterventional
SexWomen only
Enrollment50 (estimated)
SponsorYunnan Cancer Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Kunming, Yunnan)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedOctober 26, 2026
Trial IDNCT07886320 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–75 with breast cancer or head and neck cancer planning involved-field radiotherapy and who have grade I–III radiation dermatitis.

Probably not a fit

Patients without radiation dermatitis progression or those not meeting inclusion criteria may not benefit from this topical approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This early-phase, randomized trial compares topical adapalene gel 0.1% to Biafine for treating acute radiation-induced skin injury in adults with breast cancer or head and neck cancer. Participants will apply the assigned treatment daily during radiotherapy and visit the clinic every five days for skin assessments, imaging, labs, and symptom reporting. Outcomes include skin reaction severity, safety signals, inflammatory markers, symptoms, and quality of life at multiple time points during treatment and follow-up. The study aims to establish timing, dose, safety monitoring, and potential clinical benefit of topical retinoids for radiation dermatitis across different injury grades.

Why it matters

Potential benefit: If successful, patients may experience reduced skin damage and improved comfort during radiotherapy.

How similar studies have gone: Previous research on topical retinoids for radiation dermatitis is limited; this study explores a novel application in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Informed consent: All subjects must voluntarily participate in the study and sign a written informed consent form that meets the requirements of the ethics committee.
* Male or female, aged between 18 and 75 years.
* Histologically or cytologically confirmed breast cancer or squamous cell carcinoma of the head and neck.
* Planned to receive involved-field radiotherapy (post-breast cancer surgery whole breast/chest wall ± regional lymph node irradiation).

Exclusion Criteria:

* Patients unable to cooperate with the study: cognitive impairment, severe mental illness, communication disorders, or other reasons (such as extreme anxiety, uncontrollable pain) that prevent understanding and active cooperation with the research process and postoperative care.
* Any previous or current illnesses, treatments, or laboratory abnormalities that may confound the study results, affect the subjects' full participation in the study, or involve participation that may not be in the subjects' best interests.

Where it's running

  • Yunnan Cancer Hospital
    Kunming, Yunnan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.